Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12268783 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Philip V. Felice | 2025-04-08 |
| 10548905 | Amorphous onapristone compositions and methods of making the same | Stefan Proniuk | 2020-02-04 |
| 10376464 | Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine | Philip V. Felice | 2019-08-13 |
| 10328070 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2019-06-25 |
| 10166228 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2019-01-01 |
| 9980958 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2018-05-29 |
| 9896411 | Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine | Philip V. Felice | 2018-02-20 |
| 9827240 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2017-11-28 |
| 9603937 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Philip V. Felice | 2017-03-28 |
| 9603938 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Philip V. Felice | 2017-03-28 |
| 9603939 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Philip V. Felice | 2017-03-28 |
| 9556189 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2017-01-31 |
| 9365580 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2016-06-14 |
| 9289440 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2016-03-22 |
| 9289439 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2016-03-22 |
| 9289438 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2016-03-22 |
| 9221830 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2015-12-29 |
| 8975272 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2015-03-10 |
| 8735420 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2014-05-27 |
| 8685948 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2014-04-01 |
| 8476250 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2013-07-02 |
| 8389540 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2013-03-05 |
| 8304404 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2012-11-06 |
| 8173625 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Philip V. Felice | 2012-05-08 |
| 7279579 | Polymorphic forms of naltrexone | David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright | 2007-10-09 |